logo
Crocs Sinks After Third-Quarter Forecast for Sharp Sales Decline

Crocs Sinks After Third-Quarter Forecast for Sharp Sales Decline

Bloomberg5 days ago
Crocs Inc. shares dropped after the shoe company said its efforts to save money amid consumer pressure and tariffs would drive down revenue.
The company forecast a third-quarter revenue decline of approximately 9% to 11%. Analysts on average expected sales to gain less than 1%.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Airbnb's New Strategy: ‘Aggressively' Add Hotels, Steal Their Guests
Airbnb's New Strategy: ‘Aggressively' Add Hotels, Steal Their Guests

Skift

time2 minutes ago

  • Skift

Airbnb's New Strategy: ‘Aggressively' Add Hotels, Steal Their Guests

Airbnb has long sought to add hotels into its inventory mix, but the dilemma has been how to do so and not become just another online travel agency like or Expedia. Airbnb says it is getting more aggressive in a new strategy to add hotels in markets where most of the short-term rentals are already booked, and to convince more hotel guests to stay in Airbnbs. CEO Brian Chesky told financial analysts last week that Airbnb is "going significantly more aggressively into hotels. We've spent a lot of time looking at hotels as a business. We think it's really compelling." Chesky said the commissions Airbnb receives from hotels are "very, very competitive," adding that the company has engaged in dialogue with hotels around t

Spirit's survival hinges on finding more cash
Spirit's survival hinges on finding more cash

Fast Company

time2 minutes ago

  • Fast Company

Spirit's survival hinges on finding more cash

NEWS Without a cash boost, the budget airline's comeback could stall out. [Photos: David Sypher /Unsplash, Yeti Studio/Adobe Stock] BY Spirit Airlines can't seem to reach its cruising altitude. The budget airline issued a warning late Monday that if it doesn't find an infusion of cash, its business is poised to fail. Spirit expressed the dire state of its financials in its quarterly earnings report, filed late Monday. The report comes less than six months after the beleaguered airline emerged from bankruptcy with a plan to right its business and pursue profitability. 'Management has concluded there is substantial doubt as to the Company's ability to continue as a going concern within 12 months from the date these financial statements are issued,' the company wrote in the filing, citing a scenario in which the company fails to hold the liquid assets needed to meet its debt obligations and keep its credit card processor. To steer itself out of the crisis, Spirit is pursuing 'liquidity enhancing measures' that could include selling some of its aircraft or real estate and offloading some of its extra airport gate capacity. 'While it is the Company's goal to execute on these initiatives, there can be no assurance that such initiatives will be successful,' the company wrote. Spirit cut 200 jobs back in January as part of its plan to slash $80 million in costs. Last year, the company sold 23 Airbus planes – more than 10% of its fleet – to drum up emergency cash. 'As you all know, we're facing significant challenges with our business, which is why we've been focused on taking actions to optimize our organization and create more efficiencies,' Spirit CEO Ted Christie told staff in an internal memo early this year. 'The bottom line is, we need to run a smaller airline and get back on better financial footing.' Recent problems, Frontier bailout Spirit filed for Chapter 11 bankruptcy late last year in light of mounting losses, a pile of debt and failed merger negotiations. The airline continued to operate during that time frame, which coincided with the busy holiday travel season. 'The most important thing to know is that you can continue to book and fly now and in the future,' the company wrote in an open letter to customers at the time. Spirit was in talks with JetBlue to combine the two airlines back in 2023, but the ill-fated merger faced stiff opposition. The Justice Department sued to block the $3.8 billion deal over antitrust concerns and ultimately a federal judge sided with the government, sounding the merger's death knell. Earlier this year, Spirit rejected a different merger offer from fellow budget carrier Frontier. Frontier revised the offer, but Spirit declined to move forward with the deal, which would have been worth around $2.16 billion. At the time, the company insisted that going it alone and pursuing its post-bankruptcy restructuring plan would benefit shareholders more than doubling up with another airline. The airline industry is in a strange transitional phase in 2025. Normal U.S. carriers are looking to rebrand themselves as 'lifestyle' airlines while credit card companies double down on luxe travel perks designed to make air travel more bearable. The industry's already wafer-thin margins are threatened by Trump's endless parade of tariffs and the economic chaos they sow. Meanwhile, a spate of U.S. aviation disasters has led to tanking trust in air travel and calls for a national overhaul of the air traffic control system that undergirds the whole industry. How – and if – budget airlines fit into the future of travel is an open question, but it's one Spirit needs to answer if it plans to survive. Unfortunately for the troubled airline, time is running out. The early-rate deadline for Fast Company's Most Innovative Companies Awards is Friday, September 5, at 11:59 p.m. PT. Apply today. ABOUT THE AUTHOR Taylor Hatmaker is a writer and photographer based on the West Coast. She was previously a Senior Editor at TechCrunch, where she specialized in social media, gaming and online culture. More

What's Really Inside Your Supplements? This Founder Is Uncovering the Truth Behind the $180 Billion Industry
What's Really Inside Your Supplements? This Founder Is Uncovering the Truth Behind the $180 Billion Industry

Entrepreneur

time2 minutes ago

  • Entrepreneur

What's Really Inside Your Supplements? This Founder Is Uncovering the Truth Behind the $180 Billion Industry

From creatine to NAD+, this company is uncovering the truth behind mislabeled, underdosed and overhyped products. Opinions expressed by Entrepreneur contributors are their own. I recently wrote about creatine and profiled Jeff Byers, co-founder of Momentous, for a reason: integrity matters. When it comes to what we put in our bodies, especially for entrepreneurs aiming to optimize energy, recovery and longevity, founders and consumers deserve transparency and truth. And yet, the supplement industry is booming with very little of either. We're in the middle of a health optimization gold rush. Creatine gummies, NAD+ capsules, sleep pills and brain-boosting stacks are everywhere. Scroll Instagram, walk into Erewhon or search Amazon, and you'll find thousands of options. The global supplement industry is growing fast and is expected to top $240 billion by 2028, yet many of these products do not contain what they claim to. You may be spending $30, $50 or $90 on a supplement and getting barely a trace of the active ingredient, or in some cases, nothing at all. Unlike pharmaceuticals, supplements don't require FDA approval before hitting the market. That creates a loophole where products can launch quickly, and claims, unless dangerously false, go largely unchecked. And it's not just obscure or small brands. Some of the top-selling supplements on Amazon are underdelivering, misleading or worse. That's where Steve Martocci and SuppCo come in. Martocci, best known for founding the music-tech platform Splice, is now on a mission to fix one of the most frustrating problems in wellness: a lack of transparency. SuppCo is a health tech startup that independently tests supplements and publishes public reports that give consumers one thing the industry often avoids: truth. CEO and Co-Founder, Martocci, struggled with his health for most of his life, reaching nearly 300 pounds despite playing three sports and training consistently. Martocci said to me, "Traditional medicine failed me. I remember being told my labs were on the 'low end of normal' and that nothing could be done. It was completely disheartening." After selling GroupMe to Skype, Martocci discovered functional medicine and began working with a doctor on a tailored supplement stack. He lost nearly 100 pounds over the next year and realized that even though supplements had become mainstream, there was no software actually to help people navigate this space. The supplement industry is a $180 billion market, yet it's filled with confusion, noise and a multitude of products that don't deliver what they promise. With SuppCo, Martocci is on a mission to transform how people discover, manage and optimize their supplement routines. Join top CEOs, founders and operators at the Level Up conference to unlock strategies for scaling your business, boosting revenue and building sustainable success. I was introduced to SuppCo's work through their recent Creatine Gummies Report. Creatine, which I personally take and have written about, is one of the most well-researched supplements for both brain and physical performance. But not all products are created equal. SuppCo tested five popular creatine gummy brands sold on Amazon. Only two passed. One contained less than 25% of the labeled amount. SuppCo recently published a report on NAD+ supplements, a trending ingredient in the longevity and cellular energy space, which tested nine products and was even more revealing. 4 passed (Double Wood, Rho Nutrition Liposomal, NatureBell and Thinbi), with Thinbi exceeding its claim at 103%. 5 failed, including Maripolio, which showed 0% of its claimed NAD+. Others tested at less than 3% of the listed amount on the label. NAD+ was the perfect follow-up to the creatine testing series because it represents everything confusing about the supplement space right now. Martocci explained that NAD+ is one of the fastest-rising compounds in longevity and biohacking, endorsed by scientists and influencers, but it's also one of the most confusing for consumers. Martocci said, "You can supplement with NAD+ itself or its precursors like NR and NMN, and most consumers don't understand the bioavailability differences between the three and that one of them is distinctly worse." When we see brands cutting corners on things we can measure, like certifications and testing transparency, they're usually cutting corners on things we can't see too, like what's actually in the bottle. As NAD+ continues to trend for its role in cellular repair and longevity, the gap between marketing and reality becomes even more concerning. Related: Why Top Entrepreneurs Are Swapping Beach Vacations for Longevity Retreats If you're a wellness founder, product integrity is not just a checkbox. It is the heartbeat of your brand. Jeff Byers' company, Momentous, invests in clinical research and testing not because it is required, but because it is what builds lasting trust. Byers told me, "That means showing the science, backing it up with testing, and being radically transparent with our consumers." The next generation of wellness brands will not win on hype. They'll win on data. Consumers are becoming smarter and more demanding, and they want to see the data. SuppCo has already rated over 700 brands and 22,000+ products, and their TrustScore has become remarkably predictive of testing. Now, quality brands are reaching out not just to request a TrustScore, but to get feedback on how to improve their quality practices. When choosing supplements, most people go wrong by treating supplements as if they were all the same. For example, they'll buy the cheapest magnesium without realizing that magnesium oxide has terrible bioavailability compared to magnesium glycinate. Or they'll choose a multivitamin based on how many vitamins are crammed into it, not whether those forms and doses actually work together. Jenna Stangland, co-founder of A4 health and Dietitian for the Minnesota Timberwolves and Minnesota Wild, explains how important it is to ensure that a supplement is tested and validated, as most likely, the dose on the label may not match what is in the bottle and even worse, it could be contaminated. Stangland personally takes NAD+ regularly to support her own energy and help her body adapt to stress and inflammation as she's on airplanes and traveling with teams multiple times per week. Having only tested the creatine and NAD+ categories, SuppCo is just getting started. The company plans to test every major supplement category where there's confusion or questionable quality. This includes protein, magnesium, pre-workouts and nootropics — anywhere consumers are making decisions based on incomplete information, their aim is to bring transparency. Related: Are Your Employees Stressed? You Need to Embrace Transparency. A big milestone they hit recently is the launch of SuppCo Pro, a premium subscription that unlocks deep personalization features. They have received strong user response to their Personal Nutrient Plan, which creates tailored supplement recommendations based on a user's specific goals, as well as their Product Optimizer, which suggests higher-quality, better-value alternatives to what a user is currently taking. This is where the real magic happens, as they can offer truly personalized guidance. I personally appreciate how easy it is to understand their public reports. On the app, you can quickly see whether a product passed or failed, and why. They even launched a browser extension that flags whether the supplement you're browsing has been independently tested. For those of us who care deeply about healthspan, recovery and long-term performance, this kind of transparency is a game-changer.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store